A Prospective Randomised, Open, Multicentre, Phase III Study to Assess Different Durations of Anastrozole Therapy After 2 to 3 Years Tamoxifen as Adjuvant Therapy in Postmenopausal Women With Breast Cancer
Latest Information Update: 23 Feb 2023
At a glance
- Drugs Anastrozole (Primary)
- Indications Early breast cancer
- Focus Registrational; Therapeutic Use
- Acronyms DATA
- Sponsors AstraZeneca
- 17 Feb 2023 Status changed from active, no longer recruiting to completed.
- 13 Sep 2022 Results presented at the 47th European Society for Medical Oncology Congress
- 05 Jun 2018 Results assessing patterns of care in detection and treatment of osteopenia/osteoporosis and linear trends over time in bone mineral density presented at the 54th Annual Meeting of the American Society of Clinical Oncology